bullish
Japan Pharma - FY17e Earnings Preview (I)
98 Views24 Apr 2018 22:17
Astellas Pharma Inc (4503 JP) - April 26, 2018FY18e potential guidance
Moderate Xtandi and Tarceva growth and Vesicare US patent expiry led y-o-y...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
x